Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications
Soft tissue sarcomas are a rare and multifaceted group of solid tumours. Neoadjuvant chemotherapy is increasingly used to limit loss of function after wide surgical excision with the ultimate aim of improving patient survival. Recently, advances in the identification of effective treatment strategie...
Main Authors: | Sandro Pasquali, Alessandro Gronchi |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-06-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758834017705588 |
Similar Items
-
Staging Systems and Nomograms for Soft Tissue Sarcoma
by: Maria Danieli, et al.
Published: (2023-03-01) -
Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations
by: Gino K. In, et al.
Published: (2017-08-01) -
Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report
by: Ronak Patel, et al.
Published: (2019-01-01) -
Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma
by: Filippo Torrigiani, et al.
Published: (2019-07-01) -
Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapyResearch in context
by: Sandro Pasquali, et al.
Published: (2024-08-01)